This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Tinto H, Ouedraogo JB, Erhart A, Van Overmeir C, Dujardin JC, Van Marck E, et al. Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect Genet Evol. 2003; 3:287-92.10.1016/j.meegid.2003.08.00214636690TintoHOuedraogoJBErhartAVanOvermeir CDujardinJCVanMarck Eet alRelationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa2003328792Open DOISearch in Google Scholar
Happi TC, Thomas SM, Gbotosho GO, Falade CO, Akinboye DO, Gerena L, et al. Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Ann Trop Med Parasitol. 2003; 97:439-51.10.1179/00034980323500248912930607HappiTCThomasSMGbotoshoGOFaladeCOAkinboyeDOGerenaLet alPoint mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria20039743951Open DOISearch in Google Scholar
Dorsey G, Kamya MR, Singh A, Rosenthal PJ. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis. 2001; 183:1417-20.10.1086/31986511294677DorseyGKamyaMRSinghARosenthalPJPolymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda2001183141720Open DOISearch in Google Scholar
Price R, Robinson G, Brockman A, Cowman A, Krishna S. Assessment of pfmdr 1 gene copy number by tandem competitive polymerase chain reaction. Mol Biochem Parasitol. 1997; 85:161-9.10.1016/S0166-6851(96)02822-89106190PriceRRobinsonGBrockmanACowmanAKrishnaSAssessment of pfmdr 1 gene copy number by tandem competitive polymerase chain reaction1997851619Open DOISearch in Google Scholar
Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G, Targett GA, et al. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology. 1997; 114:205-11.10.1017/S00311820960084879075340DuraisinghMTDrakeleyCJMullerOBaileyRSnounouGTargettGAet alEvidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine199711420511Open DOISearch in Google Scholar
Borrmann S, Adegnika AA, Missinou MA, Binder RK, Issifou S, Schindler A, et al. Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon. Antimicrob Agents Chemother. 2003; 47:901-4.10.1128/AAC.47.3.901-904.200312604519BorrmannSAdegnikaAAMissinouMABinderRKIssifouSSchindlerAet alShort-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon2003479014Open DOISearch in Google Scholar
Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast Asian J Trop Med Public Health. 1991; 22:539-43.1820641BunnagDViravanCLooareesuwanSKarbwangJHarinasutaTDouble blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria19912253943Search in Google Scholar
Li GQ, Guo XB, Fu LC, Jian HX, Wang XH. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg. 1994; 88 Suppl 1:S5-6.8053027LiGQGuoXBFuLCJianHXWangXHClinical trials of artemisinin and its derivatives in the treatment of malaria in China199488 Suppl 1S5610.1016/0035-9203(94)90460-XSearch in Google Scholar
Ho M, Davis TM, Silamut K, Bunnag D, White NJ. Rosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria. Infect Immun. 1991; 59:2135-9.2037374HoMDavisTMSilamutKBunnagDWhiteNJRosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria1991592135910.1128/iai.59.6.2135-2139.1991Search in Google Scholar
Alin MH, Kihamia CM, Bjorkman A, Bwijo BA, Premji Z, Mtey GJ, et al. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine. Am J Trop Med Hyg. 1995; 53:639-45.10.4269/ajtmh.1995.53.6398561267AlinMHKihamiaCMBjorkmanABwijoBAPremjiZMteyGJet alEfficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine19955363945Open DOISearch in Google Scholar
Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Public Health. 1991; 22:534-8.1820640BunnagDViravanCLooareesuwanSKarbwangJHarinasutaTDouble blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria1991225348Search in Google Scholar
Anstey NM, Hassanali M Y, Mlalasi J, Manyenga D, Mwaikambo ED. Elevated levels of methaemoglobin in Tanzanian children with severe and uncomplicated malaria. Trans R Soc Trop Med Hyg. 1996; 90:147-51.876157510.1016/S0035-9203(96)90118-2AnsteyNMHassanaliM YMlalasiJManyengaDMwaikamboEDElevated levels of methaemoglobin in Tanzanian children with severe and uncomplicated malaria19969014751Search in Google Scholar
Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008; 359: 2619-20.10.1056/NEJMc080501119064625NoedlHSeYSchaecherKSmithBLSocheatDFukudaMMet alEvidence of artemisinin-resistant malaria in western Cambodia200835926192019064625Open DOISearch in Google Scholar
Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, et al. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS One. 2011; 6:e19283.10.1371/journal.pone.0019283BethellDSeYLonCTynerSSaundersDSriwichaiSet alArtesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial20116e19283309435521603629Open DOISearch in Google Scholar
Tyner SD, Lon C, Se Y, Bethell D, Socheat D, Noedl H, et al. Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay. Malar J. 2012; 11:198.10.1186/1475-2875-11-19822694953TynerSDLonCSeYBethellDSocheatDNoedlHet alEx vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay201211198340398822694953Open DOISearch in Google Scholar
Saunders D, Khemawoot P, Vanachayangkul P, Siripokasupkul R, Bethell D, Tyner S, et al. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia. Antimicrob Agents Chemother. 2012; 56:5484-93.2286958110.1128/AAC.00044-12SaundersDKhemawootPVanachayangkulPSiripokasupkulRBethellDTynerSet alPharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia201256548493348659922869581Search in Google Scholar
Krishna S, Kremsner PG. Artemisinin resistance needs to be defined rigorously to be understood: response to Dondorp and Ringwald. Trends Parasitol. 2013; 29: 361-2.2380986510.1016/j.pt.2013.05.006KrishnaSKremsnerPGArtemisinin resistance needs to be defined rigorously to be understood: response to Dondorp and Ringwald201329361223809865Search in Google Scholar
Krishna S, Kremsner PG. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends Parasitol. 2013; 29:313-7.10.1016/j.pt.2013.04.00123623760KrishnaSKremsnerPGAntidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy201329313723623760Open DOISearch in Google Scholar
Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 2003; 424: 957-61.1293119210.1038/nature01813Eckstein-LudwigUWebbRJVanGoethem IDEastJMLeeAGKimuraMet alArtemisinins target the SERCA of Plasmodium falciparum20034249576112931192Search in Google Scholar
Pulcini S, Staines HM, Pittman JK, Slavic K, Doerig C, Halbert J, et al. Expression in yeast links field polymorphisms in PfATP6 to in vitro artemisinin resistance and identifies new inhibitor classes. J Infect Dis. 2013; 208:468-78.10.1093/infdis/jit17123599312PulciniSStainesHMPittmanJKSlavicKDoerigCHalbertJet alExpression in yeast links field polymorphisms in PfATP6 to in vitro artemisinin resistance and identifies new inhibitor classes20132084687823599312Open DOISearch in Google Scholar
Uhlemann AC, Krishna S. Antimalarial multi-drug resistance in Asia: mechanisms and assessment. Curr Top Microbiol Immunol. 2005; 295:39-53.16265886UhlemannACKrishnaSAntimalarial multi-drug resistance in Asia: mechanisms and assessment2005295395310.1007/3-540-29088-5_216265886Search in Google Scholar
Uhlemann AC, Ramharter M, Lell B, Kremsner PG, Krishna S. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis. 2005; 192:1830-5.1623518510.1086/497337UhlemannACRamharterMLellBKremsnerPGKrishnaSAmplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon20051921830516235185Search in Google Scholar
Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, et al. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol. 2005; 12: 628-9.1593749310.1038/nsmb947UhlemannACCameronAEckstein-LudwigUFischbargJIserovichPZunigaFAet alA single amino acid residue can determine the sensitivity of SERCAs to artemisinins2005126289Search in Google Scholar
Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, et al. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005; 366: 1960-3.1632569810.1016/S0140-6736(05)67787-2JambouRLegrandENiangMKhimNLimPVolneyBet alResistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6200536619603Search in Google Scholar
Ma H, Lewis D, Xu C, Inesi G, Toyoshima C. Functional and structural roles of critical amino acids within the “N”, “P”, and “A” domains of the Ca2+ ATPase (SERCA) headpiece. Biochemistry. 2005; 44:8090-100.10.1021/bi050332mMaHLewisDXuCInesiGToyoshimaCFunctional and structural roles of critical amino acids within the “N”, “P”, and “A” domains of the Ca2+ ATPase (SERCA) headpiece2005448090100Open DOISearch in Google Scholar
Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis. 2010; 51:e82-9.2102898510.1086/657120NoedlHSeYSriwichaiSSchaecherKTeja-IsavadharmPSmithBet alArtemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia201051e829Search in Google Scholar
Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004; 364:438-47.10.1016/S0140-6736(04)16767-615288742PriceRNUhlemannACBrockmanAMcGreadyRAshleyEPhaipunLet alMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number200436443847Open DOISearch in Google Scholar
Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, et al. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2010; 54:2886-92.2042139510.1128/AAC.00032-10ImwongMDondorpAMNostenFYiPMungthinMHanchanaSet alExploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum201054288692289728720421395Search in Google Scholar
Miao M, Wang Z, Yang Z, Yuan L, Parker DM, Putaporntip C, et al. Genetic diversity and lack of artemisinin selection signature on the Plasmodium falciparum ATP6 in the Greater Mekong Subregion. PloS one. 2013; 8:e59192.10.1371/journal.pone.005919223555629MiaoMWangZYangZYuanLParkerDMPutaporntipCet alGenetic diversity and lack of artemisinin selection signature on the Plasmodium falciparum ATP6 in the Greater Mekong Subregion20138e59192360860923555629Open DOISearch in Google Scholar
Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet. 2013; 45:648-55.2362452710.1038/ng.2624MiottoOAlmagro-GarciaJManskeMMacinnisBCampinoSRockettKAet alMultiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia20134564855380779023624527Search in Google Scholar
Takala-Harrison S, Clark T G, Jacob C G, Cummings M P, Miotto O, Dondorp AM, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci USA. 2013; 110:240-5.10.1073/pnas.1211205110Takala-HarrisonSClarkT GJacobC GCummingsM PMiottoODondorpAMet alGenetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia20131102405353824823248304Open DOISearch in Google Scholar
Winzeler EA, Manary MJ. Drug resistance genomics of the antimalarial drug artemisinin. Genome Biol. 2014; 15:544.10.1186/s13059-014-0544-625470531WinzelerEAManaryMJDrug resistance genomics of the antimalarial drug artemisinin201415544428357925470531Open DOISearch in Google Scholar
Cardi D, Pozza A, Arnou B, Marchal E, Clausen JD, Andersen JP, et al. Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins. J Biol Chem. 2010; 285:26406-16.10.1074/jbc.M109.09034020530490CardiDPozzaAArnouBMarchalEClausenJDAndersenJPet alPurified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins20102852640616292407120530490Open DOISearch in Google Scholar
Cui L, Wang Z, Jiang H, Parker D, Wang H, Su XZ, et al. Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins. Antimicrob Agents Chemother. 2012; 56:2546-52.10.1128/AAC.05943-1122354307CuiLWangZJiangHParkerDWangHSuXZet alLack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins201256254652334663122354307Open DOISearch in Google Scholar
Valderramos SG, Scanfeld D, Uhlemann AC, Fidock DA, Krishna S. Investigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance. Antimicrob Agents Chemother. 2010; 54:3842-52.2056676210.1128/AAC.00121-10ValderramosSGScanfeldDUhlemannACFidockDAKrishnaSInvestigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance201054384252293501720566762Search in Google Scholar
Abiodun OO, Brun R, Wittlin S. In vitro interaction of artemisinin derivatives or the fully synthetic peroxidic anti-malarial OZ277 with thapsigargin in Plasmodium falciparum strains. Malar J. 2013; 12:43.10.1186/1475-2875-12-4323368889AbiodunOOBrunRWittlinSIn vitro interaction of artemisinin derivatives or the fully synthetic peroxidic anti-malarial OZ277 with thapsigargin in Plasmodium falciparum strains20131243356691823368889Open DOISearch in Google Scholar
Arnou B, Montigny C, Morth JP, Nissen P, Jaxel C, Moller J V, et al. The Plasmodium falciparum Ca2+-ATPase PfATP6: insensitive to artemisinin, but a potential drug target. Biochem Soc Trans. 2011; 39: 823-31.2159965510.1042/BST0390823ArnouBMontignyCMorthJPNissenPJaxelCMollerJ Vet alThe Plasmodium falciparum Ca2+-ATPase PfATP6: insensitive to artemisinin, but a potential drug target2011398233121599655Search in Google Scholar
Cojean S, Hubert V, Le Bras J, Durand R. Resistance to dihydroartemisinin. Emerg Infect Dis. 2006; 12: 1798-9.1728364510.3201/eid1211.060903CojeanSHubertVLeBras JDurandRResistance to dihydroartemisinin20061217989337236217283645Search in Google Scholar
Krishna S, Pulcini S, Fatih F, Staines H. Artemisinins and the biological basis for the PfATP6/SERCA hypothesis. Trends Parasitol. 2010; 26:517-23.2063890410.1016/j.pt.2010.06.014KrishnaSPulciniSFatihFStainesHArtemisinins and the biological basis for the PfATP6/SERCA hypothesis2010265172320638904Search in Google Scholar
Afonso A, Hunt P, Cheesman S, Alves AC, Cunha CV, do Rosario V, et al. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Antimicrob Agents Chemother. 2006; 50: 480-9.1643670010.1128/AAC.50.2.480-489.2006AfonsoAHuntPCheesmanSAlvesACCunhaCVdoRosario Vet alMalaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg102006504809136692116436700Search in Google Scholar
Bacon DJ, McCollum AM, Griffing SM, Salas C, Soberon V, Santolalla M, et al. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrobial agents and chemotherapy. 2009; 53:2042-51.10.1128/AAC.01677-0819258269BaconDJMcCollumAMGriffingSMSalasCSoberonVSantolallaMet alDynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria200953204251268156619258269Open DOISearch in Google Scholar
Tanabe K, Zakeri S, Palacpac NM, Afsharpad M, Randrianarivelojosia M, Kaneko A, et al. Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies. Antimicrob Agents Chemother. 2011; 55:94-100.2095659310.1128/AAC.01156-10TanabeKZakeriSPalacpacNMAfsharpadMRandrianarivelojosiaMKanekoAet alSpontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies20115594100301964920956593Search in Google Scholar
Bhisutthibhan J, Pan XQ, Hossler PA, Walker DJ, Yowell CA, Carlton J, et al. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem. 1998; 273:16192-8.963267510.1074/jbc.273.26.16192BhisutthibhanJPanXQHosslerPAWalkerDJYowellCACarltonJet alThe Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin19982731619289632675Search in Google Scholar